Global Partnerships AUM Biosciences has established strategic partnerships with companies like Handok Inc. and CMG Pharmaceutical for the development, commercialization, and manufacturing rights of innovative cancer therapeutics. Leveraging these collaborations can open doors for cross-selling opportunities in the oncology space.
Series A Funding The company successfully completed a $27 million Series A funding round led by prominent investors such as Everlife and SPRIM Global Investments. This infusion of capital not only indicates investor confidence but also provides resources for potential expansion and product development, paving the way for sales growth.
Industry Recognition AUM Biosciences was honored with the 2019 Asia-Pacific Biotech Entrepreneurial Company of the Year Award, showcasing industry recognition for its innovative approach in precision oncology therapeutics. This accolade can be leveraged in sales pitches as a testament to the company's credibility and expertise.
Competitive Landscape Analyzing similar companies like AAVogen, Adverum Biotechnologies, and Apellis Pharmaceuticals provides insights into the competitive landscape. Understanding the strengths and weaknesses of competitors can help in tailoring sales strategies to highlight AUM Biosciences' unique value proposition and stand out in the market.
Market Expansion Recent expansions with investments from organizations like SPRIM Health Group and Everlife signify a growing market presence for AUM Biosciences. Sales teams can capitalize on these expansions to target new markets, forge strategic alliances, and drive revenue growth through diversified sales channels.
2
157
$10M$50M
770$100M$1B
62$10M
69$10M$50M
11$10MAUM Biosciences uses 8 technology products and services including Google Analytics, Google Font API, Font Awesome, and more. Explore AUM Biosciences's tech stack below.
| AUM Biosciences Email Formats | Percentage |
| FirstL@aumbiosciences.com | 50% |
| FirstL@aumbiosciences.com | 50% |
Biotechnology ResearchSingapore, Singapore11-50 Employees
AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance
Company Overview
Media & News
Funding & FinancialsAUM Biosciences has raised a total of $27M of funding over 2 rounds. Their latest funding round was raised on Oct 12, 2021 in the amount of $27M.
Funding & FinancialsAUM Biosciences has raised a total of $27M of funding over 2 rounds. Their latest funding round was raised on Oct 12, 2021 in the amount of $27M.
1-888-653-2347 
support@leadiq.com